NeOnc, a biotech company helmed by Dr. Thomas Chen, brings the first non-invasive intranasal drug delivery for brain cancer into the spotlight. With this revolutionary treatment, NeOnc is poised to ...
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- ...
Healthcare rarely changes overnight. More often, it evolves quietly through regulatory decisions, clinical data, and shifting patient expectations that ...
Brain-Stimulation Tools Once Limited to Researchers Are Now Reaching the Public at Home Through a First-of-Its-Kind ...
Harnessing a pervasive type of cellular messenger shows early experimental promise as a routine way of sampling and monitoring the body's response to prescription drug exposure. Experiments have ...
Bella Vida TMS offers drug-free, non-invasive therapy using magnetic pulses to stimulate electrical activity in the brain's neurons called TMS. This treatment has no side effects and is FDA cleared ...
Efficacy of intrathecal delivery of peptide-pulsed type 1 conventional dendritic cell vaccine for the treatment of breast cancer-associated leptomeningeal disease in preclinical models. This is an ...
(RTTNews) - Intelligent Bio Solutions Inc. (INBS) announced Wednesday the rapid expansion of its Intelligent Fingerprinting Drug Screening System across Sweden, Norway, and Denmark through its ...
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results